Earnings Call · Q1 FY2023·2023-05-03

Q1 23EPS +10.53%·Rev n/aQ4 22EPS -47.83%·Rev n/aQ3 22EPS +69.81%·Rev n/aQ2 22EPS -19.15%·Rev n/a⚠ consensus missing

IONIS PHARMACEUTICALS INC IONS

Wade Walke — Senior Vice President of Investor Relations

Brett Monia — Executive

Richard Geary — Executive

Beth Hougen — Executive

−2.2%1d on move date−1.5% vs SPY3d+1.9%5d+0.5%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IONS calls or request research access.

More IONS calls Browse calls Request research access